These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3603587)

  • 1. Inhibitory effect of reserpine on N-2-fluorenylacetamide-induced hepatocarcinogenesis in rats.
    Sugie S; Tanaka T; Kuniyasu T; Mori H
    Toxicol Lett; 1987 Jul; 37(2):115-9. PubMed ID: 3603587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters.
    Tanaka T; Nishikawa A; Shima H; Sugie S; Shinoda T; Yoshimi N; Iwata H; Mori H
    Basic Life Sci; 1990; 52():429-40. PubMed ID: 2327945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of polyprenoic acid (E-5166) on N-2-fluorenylacetamide-initiated hepatocarcinogenesis in rats.
    Shima H; Kuniyasu T; Sugie S; Tanaka T; Mori H; Takahashi M; Muto Y
    Jpn J Cancer Res; 1986 Apr; 77(4):351-5. PubMed ID: 3084425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats.
    Tanaka T; Iwata H; Niwa K; Mori Y; Mori H
    Jpn J Cancer Res; 1988 Dec; 79(12):1297-303. PubMed ID: 2906931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of radiation on N-2-fluorenylacetamide-induced hepatocarcinogenesis in male ACI/N rats.
    Mori H; Iwata H; Morishita Y; Mori Y; Ohno T; Tanaka T; Sasaki S
    Jpn J Cancer Res; 1990 Oct; 81(10):975-8. PubMed ID: 2121684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing effect of barbital on N-2-fluorenylacetamide-induced rat liver lesions.
    Mori H; Tanaka T; Nishikawa A; Takahashi M; Williams GM
    Gan; 1981 Oct; 72(5):798-801. PubMed ID: 7327380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying effects of anticancer drugs adriamycin, actinomycin D, and cisplatin on N-2-fluorenylacetamide-induced hepatocarcinogenesis in male ACI/N rats.
    Tanaka T; Takeuchi T; Shimizu M; Morishita Y; Mori Y; Mori H
    J Toxicol Environ Health; 1991 Mar; 32(3):269-75. PubMed ID: 2002512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of a promoting or sequential syncarcinogenic effect in rat liver by the carcinogenic hypolipidemic drug nafenopin given after N-2-fluorenylacetamide.
    Numoto S; Mori H; Furuya K; Levine WG; Williams GM
    Toxicol Appl Pharmacol; 1985 Jan; 77(1):76-85. PubMed ID: 3966244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development.
    Katayama S; Ohmori T; Maeura Y; Croci T; Williams GM
    J Natl Cancer Inst; 1984 Jul; 73(1):141-9. PubMed ID: 6588222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene.
    Maeura Y; Weisburger JH; Williams GM
    Cancer Res; 1984 Apr; 44(4):1604-10. PubMed ID: 6704970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of the non-steroidal anti-inflammatory drugs, indomethacin and piroxicam on 2-acetylaminofluorene-induced hepatocarcinogenesis in male ACI/N rats.
    Tanaka T; Kojima T; Okumura A; Sugie S; Mori H
    Cancer Lett; 1993 Feb; 68(2-3):111-8. PubMed ID: 8443783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental studies on hepatic cirrhosis and hepatocarcinogenesis. II. Influence of cirrhotic liver on 2-FAA hepatocarcinogenesis in rats.
    Shimizu A
    Acta Pathol Jpn; 1986 Jul; 36(7):1039-48. PubMed ID: 3529810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of azathioprine and carbon tetrachloride on induction of hyperplastic liver nodule and hepatocellular carcinoma by diethylnitrosamine and N-2-fluorenylacetamide in rats.
    Sakata T; Watanabe A; Takei N; Shiota T; Nakatsukasa H; Fujiwara M; Kobayashi M; Nagashima H
    Ann N Y Acad Sci; 1983; 417():288-93. PubMed ID: 6142675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenicity of betel quid. III. Enhancement of 4-nitroquinoline-1-oxide- and N-2-fluorenylacetamide-induced carcinogenesis in rats by subsequent administration of betel nut.
    Tanaka T; Kuniyasu T; Shima H; Sugie S; Mori H; Takahashi M; Hirono I
    J Natl Cancer Inst; 1986 Sep; 77(3):777-81. PubMed ID: 3091901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M; Tamura T; Kuroda J; Ohnota H; Shibata N; Akahane M; Kashida Y; Mitsumori K
    Toxicol Sci; 2005 Mar; 84(1):22-8. PubMed ID: 15564315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An enhancing effect of the antihistaminic drug methapyrilene on rat liver carcinogenesis by previously administered N-2-fluorenylacetamide.
    Furuya K; Mori H; Williams GM
    Toxicol Appl Pharmacol; 1983 Aug; 70(1):49-56. PubMed ID: 6612738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of disulfiram on rat mammary tumor induction by N-2-fluorenylacetamide and on its metabolic conversion to N-hydroxy-N-2-fluorenylacetamide.
    Malejka-Giganti D; McIver RC; Rydell RE
    J Natl Cancer Inst; 1980 Jun; 64(6):1471-7. PubMed ID: 6929383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of carbon tetrachloride and azathioprine on diethylnitrosamine and N-2-fluorenylacetamide-induced hyperplastic liver nodule and hepatocellular carcinoma.
    Sakata T
    Acta Med Okayama; 1984 Dec; 38(6):511-24. PubMed ID: 6524446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences of different polychlorinated biphenyls on cytocidal, mitoinhibitory, and nodule-selecting activities of N-2-fluorenylacetamide in rat liver.
    Hayes MA; Roberts E; Safe SH; Farber E; Cameron RG
    J Natl Cancer Inst; 1986 Apr; 76(4):683-91. PubMed ID: 2870208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene.
    Hosaka S; Kawa S; Aoki Y; Tanaka E; Yoshizawa K; Karasawa Y; Hosaka N; Kiyosawa K
    Food Chem Toxicol; 2001 Jun; 39(6):557-61. PubMed ID: 11346485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.